Abbott Laboratories (ABT)

98.58
+9.31 (10.42%)
NYSE· Last Trade: Jul 16th, 3:39 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Via Chartmill · July 16, 2026
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Streetmarketbeat.com
Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.
Via MarketBeat · July 16, 2026
Dow Jones Hangs On While Memory Chips Take Another Beatingfool.com
Why is the Dow holding up while the Nasdaq sinks? Healthcare gains are offsetting the semiconductor carnage.
Via The Motley Fool · July 16, 2026
Unusual volume S&P500 stocks in Thursday's sessionchartmill.com
Via Chartmill · July 16, 2026
Abbott Laboratories NYSE:ABT Rises on In-Line Q2 and Raised Guidancechartmill.com
Via Chartmill · July 16, 2026
Dividend Powerhouse: Abbott Laboratories (NYSE:ABT) Passes the Test for Sustainable Incomechartmill.com
Via Chartmill · July 10, 2026
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitabilitychartmill.com
Via Chartmill · July 3, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · July 16, 2026
Abbott Laboratories Q2 Earnings Call Highlightsmarketbeat.com
Abbott Laboratories (NYSE:ABT) reported second-quarter 2026 comparable sales growth of 4.8% and adjusted earnings per share of $1.31, with Chairman and Chief Executive Officer Robert Ford saying results marked an acceleration from the prior two quarters. The company reaffirmed its full-year compara
Via MarketBeat · July 16, 2026
Abbott Laboratories Reports Q2 2026 Results: Full Earnings Call Transcriptbenzinga.com
Abbott Laboratories (NYSE:ABT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts
Via Benzinga · July 16, 2026
Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 13% year on year to ...
Via StockStory · July 16, 2026
What's going on in today's pre-market session: S&P500 moverschartmill.com
Via Chartmill · July 16, 2026
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Abbott trades at a fraction of Glaukos' valuation, but one company burns cash while the other generates billions.
Via The Motley Fool · July 8, 2026
5 Dividend Kings to Buy in July with Irristable Value and Yieldmarketbeat.com
Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.
Via MarketBeat · July 8, 2026
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boomfool.com
Don't sleep on these medical device leaders.
Via The Motley Fool · July 7, 2026
5 Dividend Kings Long-Term Investors Should Own for the Next 20 Yearsfool.com
Investors can count on these stocks about as much as any to continue their decades-long runs of excellence.
Via The Motley Fool · July 7, 2026
3 Stocks to Buy and Hold: The Long-Term Play for Your Portfoliofool.com
These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.
Via The Motley Fool · July 6, 2026
If You Put $10,000 in This Dividend ETF 15 Years Ago, Here's How Much You'd Have Today (Hint: It's a Lot)fool.com
The Schwab U.S. Dividend Equity ETF is anything but boring.
Via The Motley Fool · July 3, 2026
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for investors weighing portfolio strategy.
Via The Motley Fool · July 1, 2026
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Incomefool.com
All three ETFs complement each other well in a portfolio.
Via The Motley Fool · June 30, 2026
3 No-Brainer Dividend Stocks to Buy Right Nowfool.com
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.
Via The Motley Fool · June 29, 2026
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000fool.com
Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot.
Via The Motley Fool · June 28, 2026
3 Monster Stocks to Hold for the Next 10 Yearsfool.com
These healthcare stocks may be the building blocks of a winning portfolio.
Via The Motley Fool · June 23, 2026
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?fool.com
July earnings matter, but long-term growth matters more.
Via The Motley Fool · June 20, 2026
3 High-Yield Dividend Stocks to Buy Hand Over Fist in Junefool.com
Now's the time to load up on these high-yielders.
Via The Motley Fool · June 15, 2026